Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC Piperidinium, 3-[(2-hydroxy-2,2-diphenylacetyl)oxy]-1,1-dimethyl-, bromide (1:1) | 76-90-4 | 99.9% | 420.34 | 1 ML
SDP

Supplier:  Medchemexpress LLC HY1758510MM/1ML

Encompass_Preferred

Mepenzolate bromide is an orally administered muscarinic receptor antagonist, with Kis of 0.68 and 2.6 nM for hM2R and hM3R, respectively. It can be used to suppress gastrointestinal hypermotility associated with irritable bowel syndrome, and is also identified as a GPR109A inhibitor.

  • Orally administered muscarinic receptor antagonist
  • Suppresses gastrointestinal hypermotility
  • Effective against irritable bowel syndrome
  • Functions as a GPR109A inhibitor

Catalog No. 50-003-87143


May include imposed supplier surcharges.
Only null left
Add to Cart

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.